HANDA PHARMACEUTICALS INCHANDA PHARMACEUTICALS INCHANDA PHARMACEUTICALS INC

HANDA PHARMACEUTICALS INC

No trades
See on Supercharts

6620 fundamentals

HANDA PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 6620 for the last quarter is 215.53 M TWD, and it's 0.85% lower compared to the previous quarter. The net income of Q2 24 is 102.37 M TWD.

Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: TWD
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth